Literature DB >> 11275418

Diethylphosphorylation of rat cardiac M2 muscarinic receptor by chlorpyrifos oxon in vitro.

J A Bomser1, J E Casida.   

Abstract

The acute toxicity of chlorpyrifos oxon (CPO), the metabolically-activated form of the major organophosphorus insecticide chlorpyrifos, is attributable to diethylphosphorylation of acetylcholinesterase at its esteratic site. As a secondary effect, CPO is known to compete with agonist binding to the M2 muscarinic acetylcholine receptor (mAChR). This study tests the hypothesis that [ethyl-1,2-(3)H]CPO labels the M2 mAChR in rat cardiac membrane proteins. Of four labeled protein regions observed, only one had an apparent molecular mass (70-75 kDa) consistent with that of glycosylated M2 mAChR. It was identified as M2 muscarinic receptor by Western blotting and immunoprecipitation using a cardiac-specific M2 mAChR monoclonal antibody, providing the first direct evidence for diethylphosphorylation of a muscarinic receptor. This may be a functionally important M2 mAChR site, but the toxicological relevance and species and organ specificity of diethylphosphorylation are unknown.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275418     DOI: 10.1016/s0378-4274(00)00294-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  17 in total

1.  Mass spectrometry identifies multiple organophosphorylated sites on tubulin.

Authors:  Hasmik Grigoryan; Lawrence M Schopfer; Eric S Peeples; Ellen G Duysen; Marine Grigoryan; Charles M Thompson; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-24       Impact factor: 4.219

Review 2.  Review of tyrosine and lysine as new motifs for organophosphate binding to proteins that have no active site serine.

Authors:  Oksana Lockridge; Lawrence M Schopfer
Journal:  Chem Biol Interact       Date:  2010-03-06       Impact factor: 5.192

3.  Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds.

Authors:  Edna F R Pereira; Yasco Aracava; Louis J DeTolla; E Jeffrey Beecham; G William Basinger; Edgar J Wakayama; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2014-06-06       Impact factor: 4.030

4.  Oxidative stress resulting from exposure of a human salivary gland cells to paraoxon: an in vitro model for organophosphate oral exposure.

Authors:  John M Prins; Chih-Kai Chao; Saskia M Jacobson; Charles M Thompson; Kathleen M George
Journal:  Toxicol In Vitro       Date:  2014-01-29       Impact factor: 3.500

Review 5.  Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

Authors:  A V Terry
Journal:  Pharmacol Ther       Date:  2012-03-20       Impact factor: 12.310

Review 6.  Neurotoxicity in acute and repeated organophosphate exposure.

Authors:  Sean X Naughton; Alvin V Terry
Journal:  Toxicology       Date:  2018-08-23       Impact factor: 4.221

Review 7.  Mass spectrometric analyses of organophosphate insecticide oxon protein adducts.

Authors:  Charles M Thompson; John M Prins; Kathleen M George
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

8.  Organophosphorus pesticides decrease M2 muscarinic receptor function in guinea pig airway nerves via indirect mechanisms.

Authors:  Becky J Proskocil; Donald A Bruun; Charles M Thompson; Allison D Fryer; Pamela J Lein
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

9.  In vitro sensitivity of cholinesterases and [3H]oxotremorine-M binding in heart and brain of adult and aging rats to organophosphorus anticholinesterases.

Authors:  Nikita Mirajkar; Carey N Pope
Journal:  Biochem Pharmacol       Date:  2008-08-12       Impact factor: 5.858

10.  Covalent binding of the organophosphorus agent FP-biotin to tyrosine in eight proteins that have no active site serine.

Authors:  Hasmik Grigoryan; Bin Li; Erica K Anderson; Weihua Xue; Florian Nachon; Oksana Lockridge; Lawrence M Schopfer
Journal:  Chem Biol Interact       Date:  2009-04-02       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.